These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


197 related items for PubMed ID: 32236281

  • 1. Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo.
    Chen Y, Wang Q, Li Z, Liu Z, Zhao Y, Zhang J, Liu M, Wang Z, Li D, Han J.
    Dalton Trans; 2020 Apr 28; 49(16):5192-5204. PubMed ID: 32236281
    [Abstract] [Full Text] [Related]

  • 2. Albumin-encapsulated Nanoparticles of Naproxen Platinum(IV) Complexes with Inflammation Inhibitory Competence Displaying Effective Antitumor Activities in vitro and in vivo.
    Li L, Chen Y, Wang Q, Li Z, Liu Z, Hua X, Han J, Chang C, Wang Z, Li D.
    Int J Nanomedicine; 2021 Apr 28; 16():5513-5529. PubMed ID: 34429597
    [Abstract] [Full Text] [Related]

  • 3. Multifunctional platinum(IV) complexes as immunostimulatory agents to promote cancer immunochemotherapy by inhibiting tryptophan-2,3-dioxygenase.
    Hua S, Chen F, Xu G, Gou S.
    Eur J Med Chem; 2019 May 01; 169():29-41. PubMed ID: 30852385
    [Abstract] [Full Text] [Related]

  • 4. Novel Pt(IV) complexes containing salvigenin ligand reverse cisplatin-induced resistance by inhibiting Rap1b-mediated cancer cell stemness in esophageal squamous cell carcinoma treatments.
    Zhao J, Wu K, Yang Y, Liu D, Zhang C, Li X.
    Bioorg Chem; 2024 Jun 01; 147():107384. PubMed ID: 38643568
    [Abstract] [Full Text] [Related]

  • 5. Platinum complexes can inhibit matrix metalloproteinase activity: platinum-diethyl[(methylsulfinyl)methyl]phosphonate complexes as inhibitors of matrix metalloproteinases 2, 3, 9, and 12.
    Sasanelli R, Boccarelli A, Giordano D, Laforgia M, Arnesano F, Natile G, Cardellicchio C, Capozzi MA, Coluccia M.
    J Med Chem; 2007 Jul 26; 50(15):3434-41. PubMed ID: 17583333
    [Abstract] [Full Text] [Related]

  • 6. Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX-2 and PD-L1.
    Jin S, Muhammad N, Sun Y, Tan Y, Yuan H, Song D, Guo Z, Wang X.
    Angew Chem Int Ed Engl; 2020 Dec 14; 59(51):23313-23321. PubMed ID: 32897000
    [Abstract] [Full Text] [Related]

  • 7. A potent aminonaphthalimide platinum(IV) complex with effective antitumor activities in vitro and in vivo displaying dual DNA damage effects on tumor cells.
    Wang Q, Chen Y, Li G, Zhao Y, Liu Z, Zhang R, Liu M, Li D, Han J.
    Bioorg Med Chem Lett; 2019 Oct 15; 29(20):126670. PubMed ID: 31500997
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis and biological evaluation of dihydro-2-quinolone platinum(iv) hybrids as antitumor agents displaying mitochondria injury and DNA damage mechanism.
    Liu Z, Li Z, Du T, Chen Y, Wang Q, Li G, Liu M, Zhang N, Li D, Han J.
    Dalton Trans; 2021 Jan 07; 50(1):362-375. PubMed ID: 33319888
    [Abstract] [Full Text] [Related]

  • 9. Glucose conjugated platinum(II) complex: antitumor superiority to oxaliplatin, combination effect and mechanism of action.
    Li H, Gao X, Liu R, Wang Y, Zhang M, Fu Z, Mi Y, Wang Y, Yao Z, Gao Q.
    Eur J Med Chem; 2015 Aug 28; 101():400-8. PubMed ID: 26177447
    [Abstract] [Full Text] [Related]

  • 10. On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions.
    Escolà A, Crespo M, López C, Quirante J, Jayaraman A, Polat IH, Badía J, Baldomà L, Cascante M.
    Bioorg Med Chem; 2016 Nov 15; 24(22):5804-5815. PubMed ID: 27670096
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of two novel anionic and cationic platinum complexes in the treatment of osteosarcoma.
    Igarashi K, Yamamoto N, Hayashi K, Takeuchi A, Miwa S, Odani A, Tsuchiya H.
    Anticancer Agents Med Chem; 2015 Nov 15; 15(3):390-9. PubMed ID: 25511510
    [Abstract] [Full Text] [Related]

  • 12. Nitric oxide-releasing platinum(IV) prodrug efficiently inhibits proliferation and metastasis of cancer cells.
    Dai Y, Zhu Y, Cheng J, Shen J, Huang H, Liu M, Chen Z, Liu Y.
    Chem Commun (Camb); 2020 Nov 12; 56(90):14051-14054. PubMed ID: 33103676
    [Abstract] [Full Text] [Related]

  • 13. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
    Tan MX, Wang ZF, Qin QP, Zou BQ, Liang H.
    Dalton Trans; 2020 Feb 07; 49(5):1613-1619. PubMed ID: 31942585
    [Abstract] [Full Text] [Related]

  • 14. Construction of Dual Stimuli-Responsive Platinum(IV) Hybrids with NQO1 Targeting Ability and Overcoming Cisplatin Resistance.
    Fang L, Qin X, Zhao J, Gou S.
    Inorg Chem; 2019 Feb 04; 58(3):2191-2200. PubMed ID: 30657321
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
    Kelland LR, Barnard CF, Evans IG, Murrer BA, Theobald BR, Wyer SB, Goddard PM, Jones M, Valenti M, Bryant A.
    J Med Chem; 1995 Aug 04; 38(16):3016-24. PubMed ID: 7636864
    [Abstract] [Full Text] [Related]

  • 16. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
    Ma ZY, Wang DB, Song XQ, Wu YG, Chen Q, Zhao CL, Li JY, Cheng SH, Xu JY.
    Eur J Med Chem; 2018 Sep 05; 157():1292-1299. PubMed ID: 30195239
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and biological evaluation of a novel series of glycosylated platinum(iv) complexes as antitumor agents.
    Wang Q, Huang Z, Ma J, Lu X, Zhang L, Wang X, George Wang P.
    Dalton Trans; 2016 Jun 21; 45(25):10366-74. PubMed ID: 27252024
    [Abstract] [Full Text] [Related]

  • 18. Combination of 7-hydroxycoumarin in a platinum(IV) complex derived from cisplatin enhanced cytotoxicity with multiple mechanisms of action.
    Hua W, Zhao J, Hu W, Gou S.
    J Inorg Biochem; 2018 Sep 21; 186():17-23. PubMed ID: 29807243
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands.
    Hildebrandt J, Trautwein R, Kritsch D, Häfner N, Görls H, Dürst M, Runnebaum IB, Weigand W.
    Dalton Trans; 2019 Jan 15; 48(3):936-944. PubMed ID: 30565617
    [Abstract] [Full Text] [Related]

  • 20. Syntheses, crystal structures, and biological evaluations of new dinuclear platinum(ii) complexes with 1,2,4-triazole derivatives as bridging ligands.
    Wang J, Li X, Yuan C, Su F, Wu YB, Lu L, Zhu M, Xing S, Fu X.
    Dalton Trans; 2021 Apr 07; 50(13):4527-4538. PubMed ID: 33725030
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.